Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHAPE Noninvasive Intracardiac Pressure Measurement
NCT03243942Phase 2Completed
- Sponsor
- Thomas Jefferson University
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perflutren lipid microspheres in heart failure (HF), sponsored by Thomas Jefferson University. Primary endpoints: Agreement between SHAPE and pressure catheter measurements at 1 day and Error between SHAPE and pressure catheter measurements at 1 day. Started Jun 2017; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03243942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03243942.